Evidence map›Paper›PMID 42713815›Full record

ReviewDrug development research2026

Psychotropic Drugs: A Promising Non-Antibiotic Agent to Combat Multi-Drug-Resistant Microorganisms.

Indu Singh, Haritima Singh, Divakar Sharma, Anushri Keshri, Naveen Gaurav, Megh Singh Dhakad, Mirza Masroor Ali Beg

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Drug development research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Indu SinghSchool of Pharmacy, Graphic Era Hill University, Dehradun, India.ORCID https://orcid.org/0000-0003-1751-7711
Haritima SinghDepartment of Biotechnology, Graphic Era (Deemed to be) University, Dehradun, India.
Divakar SharmaDepartment of Biotechnology, Graphic Era (Deemed to be) University, Dehradun, India.ORCID https://orcid.org/0000-0002-8735-5562
Anushri KeshriDepartment of of Biotechnology, Holy Cross Women's College, Ambikapur, India.ORCID https://orcid.org/0000-0002-6064-1358
Naveen GauravDepartment of Biotechnology, School of Basic and Applied Sciences, Shri Guru Ram Rai University, Dehradun, India.ORCID https://orcid.org/0000-0002-9170-0955
Megh Singh DhakadDepartment of Microbiology, Maulana Azad Medical College and Associated Hospital, New Delhi, India.ORCID https://orcid.org/0000-0002-9624-1102
Mirza Masroor Ali BegFaculty of Medicine, Ala-Too International University, Bishkek, Kyrgyzstan.ORCID https://orcid.org/0000-0002-4519-721X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multi-drug insensitivity (MDI) to various antibiotics and the rapid dissemination of antibiotic resistance markers among the microorganisms, particularly bacteria, has become a global concern. Annually, MDI microorganisms cause 7 × 10

Indexed as

Anti-Infective AgentsPsychotropic DrugsAnimalsAnti-Bacterial AgentsDrug RepositioningDrug Resistance, Multiple, BacterialGastrointestinal MicrobiomeHumansAnti-Bacterial AgentsAnti-Infective AgentsPsychotropic Drugsdrug repurposinggut microbiomemicroorganismsmulti‐drug insensitivity (MDI)psychotropic drugs

Identifiers

PMID42713815
PMCPMC13555662

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.